This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements about bioavailability is true? 1. Bioavailability issues are ... (Read 63 times)

NClaborn

  • Hero Member
  • *****
  • Posts: 560
Which of the following statements about bioavailability is true?
 
  1. Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained-release mechanisms.
  2. All brands of a drug have the same bioavailability.
  3. Drugs that are administered more than once a day have greater bioavailability than drugs given once daily.
  4. Combining an active drug with an inert substance does not affect bioavailability.

Question 2

When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
 
  1. The sum of the effects of each drug individually
  2. Greater than the sum of the effects of each drug individually
  3. Less than the effect of each drug individually
  4. Not predictable, as it varies with each individual



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

princessflame2016

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

1

Answer to Question 2

2




NClaborn

  • Member
  • Posts: 560
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


recede

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library